 | Drug safety Update October 2018 PDF.pdf (243KB) | 11/10/2018 | Download |
| | Rivaroxaban (Xarelto▼) after transcatheter aortic valve replacement: increase in all-cause mortality, thromboembolic and bleeding events in patients in a clinical trial.Ritonavir-containing products:... | |
| MHRA DSU September 2018 PDF.pdf (267KB) | 25/09/2018 | Download |
| | Valproate Pregnancy Prevention Programme: actions required now from GPs, specialists, and dispensers. Xofigo▼ (radium-223-dichloride): new restrictions on use due to increased risk of fracture and... | |
| Drug Safety Update MHRA Aug 2018.pdf (186KB) | 28/08/2018 | Download |
| | Esmya (ulipristal acetate) and risk of serious liver injury: new restrictions to use and requirements for liver function monitoring before, during, and after treatment | |
| Drug Safety Update MHRA July 2018 (249KB) | 18/07/2018 | Download |
| | Darunavir boosted with cobicistat: avoid use in pregnancy due to risk of treatment failure and maternal-to-child transmission of HIV-1.Pressurised metered dose inhalers (pMDI): risk of airway... | |
| Drug Safety Update MHRA June 2018.pdf (186KB) | 03/07/2018 | Download |
| | Drug safety Update MHRA June 2018 | |
| MHRA Drug Safety Update May 2018.pdf (153KB) | 04/06/2018 | Download |
| | Valproate medicines (Epilim▼, Depakote▼): Pregnancy Prevention Programme materials online. Braltus (tiotropium): risk of inhalation of capsule if placed in the mouthpiece of the inhaler. | |
| Drug Safety Update MHRA April 2018 (267KB) | 24/04/2018 | Download |
| | Drug Safety Update MHRA April 2018 | |
| MHRA DSU March 18-PDF.pdf (274KB) | 09/03/2018 | Download |
| | Drug Safety Update MHRA March 2018. daclizumab, esmya, headlice | |
| Drug Safety Update MHRA February 2018 PDF.pdf (278KB) | 13/02/2018 | Download |
| | Misoprostol vaginal delivery system (Mysodelle): reports of excessive uterine contractions (tachysystole) unresponsive to tocolytic treatment. Mycophenolate mofetil, mycophenolic acid: updated... | |
| Drug Safety Update January 2018.pdf (301KB) | 09/01/2018 | Download |
| | Daclizumab (Zinbryta▼) and risk of severe liver injury. Recombinant human erythropoietins: very rare risk of severe cutaneous adverse reactions. Drug-name confusion: reminder to be vigilant for... | |
| Drug Safety Update MHRA December 2017 (421KB) | 15/12/2017 | Download |
| | Cladribine (Litak, Leustat) for leukaemia, Gadolinium-containing contrast agents, Radium-223 dichloride (Xofigo▼), Eluxadoline (Truberzi ▼): | |
| Drug Safety Update MHRA November 2017 pdf. (357KB) | 27/11/2017 | Download |
| | Gentamicin: potential for histamine-related adverse drug reactions with some batches, Quinine: reminder of dose-dependent QT-prolonging effects; updated interactions, Oral tacrolimus products:... | |
